Warning: The NCBI web site requires JavaScript to function. more...
Breast cancer stem cell markers - the rocky road to clinical applications.
Dontu G.
Breast Cancer Res. 2008;10(5):110. Epub 2008 Sep 15.
Related citations
[Expression and significance of CD44(+)ESA(+)CD24(-/low), stem cell markers for breast cancer, in non-small-cell lung carcinoma].
Lu ZQ, Li HG, Zhang HZ, Fan MJ, Shen XM, He XX.
Ai Zheng. 2008 Jun;27(6):575-9. Chinese.
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.
Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S.
Breast Cancer Res. 2009;11(4):R46. Epub 2009 Jul 9.
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.
Fillmore CM, Kuperwasser C.
Breast Cancer Res. 2008;10(2):R25. Epub 2008 Mar 26.
Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, Taguchi T, Tamaki Y, Noguchi S.
Clin Cancer Res. 2009 Jun 15;15(12):4234-41. Epub 2009 Jun 9.
Breast cancer stem cells and intrinsic subtypes: controversies rage on.
Nakshatri H, Srour EF, Badve S.
Curr Stem Cell Res Ther. 2009 Jan;4(1):50-60. Review.
Differential expression of HIF-1α in CD44+CD24-/low breast ductal carcinomas.
Oliveira-Costa JP, Zanetti JS, Silveira GG, Soave DF, Oliveira LR, Zorgetto VA, Soares FA, Zucoloto S, Ribeiro-Silva A.
Diagn Pathol. 2011 Aug 8;6:73.
Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1.
Balicki D.
Cell Stem Cell. 2007 Nov;1(5):485-7. No abstract available.
A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
Ling LJ, Wang S, Liu XA, Shen EC, Ding Q, Lu C, Xu J, Cao QH, Zhu HQ, Wang F.
Chin Med J (Engl). 2008 Oct 20;121(20):1980-6.
Recent translational research: stem cells as the roots of breast cancer.
Chang CC.
Breast Cancer Res. 2006;8(1):103. Epub 2006 Feb 24.
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.
Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L.
Breast Cancer Res. 2008;10(1):R10. Epub 2008 Feb 1.
Generation of breast cancer stem cells through epithelial-mesenchymal transition.
Morel AP, Lièvre M, Thomas C, Hinkal G, Ansieau S, Puisieux A.
PLoS One. 2008 Aug 6;3(8):e2888.
[Pilot study on the correlation between high incidence of CD44+/CD24 -/low/ABCG2- cells and poor prognosis in breast cancer].
Gong JF, Yuan YH, Song GH, Yu J, Han Y, Jia J, Ren J.
Beijing Da Xue Xue Bao. 2008 Oct 18;40(5):465-70. Chinese.
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.
Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G.
Cell Stem Cell. 2007 Nov;1(5):555-67.
ALDH(+)/CD44(+)/CD24(-) expression in cells from body cavity fluids.
Krishan A, Sharma D, Sharma S, Hamelik RM, Ganjei-Azar P, Nadji M.
Cytometry B Clin Cytom. 2010 May;78(3):176-82.
Cancer stem cell heterogeneity in hereditary breast cancer.
Wicha MS.
Breast Cancer Res. 2008;10(2):105. Epub 2008 Apr 16.
CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.
Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL.
Br J Cancer. 2008 Feb 26;98(4):756-65. Epub 2008 Feb 12.
Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype.
Reuben JM, Lee BN, Gao H, Cohen EN, Mego M, Giordano A, Wang X, Lodhi A, Krishnamurthy S, Hortobagyi GN, Cristofanilli M, Lucci A, Woodward WA.
Eur J Cancer. 2011 Jul;47(10):1527-36. Epub 2011 Feb 19.
The more things change... the more things change: developmental plasticity of tumor-initiating mammary epithelial cells.
Lewis MT.
Breast Cancer Res. 2010;12(1):101.
Epithelial-mesenchymal transition and the stem cell phenotype.
Radisky DC, LaBarge MA.
Cell Stem Cell. 2008 Jun 5;2(6):511-2.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on